SecBot SecBot
8-K ·Filed Mar 5, 2026

SBEV

SPLASH BEVERAGE GROUP, INC.
BULLISH
Impact 8/10
Horizonweeks Processed7mo ago SEC0001731122-26-000335
8-K context-dependent: Items 7.01
Actionable Insight ▲ Bullish

Monitor for announcement of definitive agreement terms, financing plans, and shareholder approval process; the $52M+ revenue and profitability of Medterra suggest transformative potential if the deal closes

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
SBEV ▼ -67.58% at T+60d
LONG call ✗ call lost -67.58% · α vs SPY -78.88% · entry $0.5000 → $0.1621
Entry = T+0 close
Mar 5, 2026
via day close
T+1d
+8.00%
call +8.00% · α +9.31%
$0.5400
settled 8mo ago
T+5d
+4.20%
call +4.20% · α +6.44%
$0.5210
settled 8mo ago
T+20d
-14.80%
call -14.80% · α -11.01%
$0.4260
settled 7mo ago
T+60d
-67.58%
call -67.58% · α -78.88%
$0.1621
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Splash Beverage Group (SBEV) announced a non-binding letter of intent to merge with Medterra CBD, LLC, a profitable hemp and CBD operator with over $52 million in 2025 revenue. The proposed combination aims to create a public cannabinoid wellness platform positioned to benefit from potential federal regulatory reforms and a CMS CBD pilot initiative.

Key Facts

  • Splash Beverage Group entered into a non-binding LOI for a merger with Medterra CBD, LLC
  • Medterra generated over $52 million in revenue in fiscal year 2025 and was profitable
  • The combined company would target leadership in the cannabinoid wellness market
  • Management believes the transaction positions the company to participate in a potential CMS CBD pilot initiative with reimbursement pathways
  • The deal is subject to definitive agreements, shareholder approval, and NYSE American listing requirements

Financial Impact

Medterra generated over $52 million in revenue in 2025 and was profitable, significantly enhancing Splash's scale and fundamentals

revenueprofitabilitymarket positioning

Risk Factors

  • Transaction is non-binding and subject to definitive agreements
  • Requires shareholder and exchange approvals
  • Dependent on raising capital to repay Medterra's indebtedness
  • Regulatory uncertainty in the cannabinoid industry

Market Snapshot

Exchange
OTC

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001731122-26-000335
Document: e7394_ex99-1.htm0001731122-26-000335
Document: 0001731122-26-000335-index-headers.html0001731122-26-000335
Document: 0001731122-26-000335-index.html0001731122-26-000335
Document: 0001731122-26-000335.txt0001731122-26-000335
15 reports for SBEV
Performance horizon
80% Hit rate @ T+5 4 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +63.00%May 5, 2026
Filters
Rows
Reports for SBEV — sortable, filterable
TypeNow
Oct 7, 2026
19d ago
DEFA14A
NEUTRAL ★ 2/10
—awaiting T+5——
Aug 25, 2026
9w ago
8-K
NEUTRAL ★ 4/10
$0.4715awaiting T+5——
Aug 21, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$0.4376awaiting T+5——
Aug 20, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$0.4250awaiting T+5——
Aug 12, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$0.4096 $0.4104▲ +0.20%▲ +0.64%—
Aug 7, 2026
11w ago
S-1
BEARISH ★ 6/10
$0.4122 $0.3780▲ +8.30%▲ +8.25%—
Aug 5, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$0.4250 $0.4096▼ −3.62%▼ −3.97%—
Jul 14, 2026
15w ago
8-K
NEUTRAL ★ 5/10
$0.1043 $0.0936▼ −10.26%▼ −9.79%—
Jul 9, 2026
15w ago
8-K
BEARISH ★ 6/10
$0.1653 $0.0936▲ +43.38%▲ +43.24%—
Jul 6, 2026
16w ago
8-K
MIXED ★ 6/10
$0.2081 $0.1240▼ −40.41%▼ −40.13%—
Showing 10 of 15

US Market Status

Market Open — Closes in 6h 8m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026